SCHOTT Vials DC Demonstrate Resistance against Delamination in New Screening Study

Published on: 

Sponsored Content

A new series of studies has demonstrated the effectiveness of SCHOTT Vials Delamination Controlled (DC), which can replace existing packaging solutions without re-registration and offers higher product security.

A new series of studies has once again demonstrated the effectiveness of SCHOTT Vials Delamination Controlled (DC). These pharmaceutical vials have a particularly high chemical durability and are therefore less susceptible to delamination. SCHOTT has had this property confirmed in various storage studies. First, substances were used that have already caused product recalls due to delamination. In a second series of studies, the question of how effectively buffer systems can be stored in the new bottle was examined more closely. The result: if the respective substances were stored in SCHOTT Vials DC, the vials remained stable and no glass delamination was observed.

Thanks to SCHOTT Vials DC, pharmaceutical companies now have an interesting alternative course of action against the “phenomenon of delamination”. SCHOTT Vials DC are based on established hot forming principles without any additional post process steps and can therefore replace the packaging that is already being used with approved drugs without causing expensive re-registration. The vials are available in the ISO sizes 2R to 10R. SCHOTT has also already produced larger sizes to meet individual customer needs.



Company name:  SCHOTT AG, Germany
Name of product: SCHOTT Vials DC